| Mr Ryan Mark Taylor, LPTA | |
|
400 Veterans Ave, Biloxi, MS 39531-2410 | |
| (228) 523-5197 | |
| Not Available |
| Full Name | Mr Ryan Mark Taylor |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 400 Veterans Ave, Biloxi, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578294658 | NPI | - | NPPES |
| PTA3165 | Other | MS | ALL COMMERCIAL INSURANCES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | PTA3165 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ryan Mark Taylor, LPTA 23336 Autumn Hills Dr, Saucier, MS 39574-7124 Ph: (228) 697-1491 | Mr Ryan Mark Taylor, LPTA 400 Veterans Ave, Biloxi, MS 39531-2410 Ph: (228) 523-5197 |
News Archive
Increasing the consumption of whole grain products and ensuring the successful introduction of functional cereal based foods requires an understanding of the views of consumers. The HEALTHGRAIN project of the European Union performed two consumer studies, each in four European countries, in order to study consumer expectations of healthy cereal foods, and assess the effect of claims and cues on consumer perception.
Being apart from your newborn while he or she is cared for the in the neonatal intensive care unitcan be heart-wrenching. To make the separation a little bit easier, The Valley Hospital in Ridgewood, NJ, has introduced an innovative system that allows parents and extended family members to conduct "virtual visits" with their little ones via webcam.
A team of scientists led by Dr Bhaskar Bhattacharya and Associate Professor Richie Soong from the Cancer Science Institute of Singapore at the National University of Singapore conducted a study on acquired resistance (AQR) to combination drug treatment in cancer and found that the mechanisms of AQR for the combination drugs were different from that of the individual drugs.
Biomarkers, which allow diseases to be diagnosed and staged based on relatively non-invasive blood tests, have been identified for several types of cancers, but for most cancers remain elusive. Now, research conducted at the RIKEN Center for Life Science Technologies in Japan and the Harry Perkins Institute of Medical Research in Australia has identified a large number of genes that are upregulated in many different types of cancer, opening the door for developing biomarker tests that could be used to detect cancers early, allowing for prompt treatment.
A molecularly engineered therapy selectively embeds a gene in pancreatic cancer that shrinks or eradicates tumors, inhibits metastasis, and prolongs survival with virtually no toxicity, researchers from The University of Texas M. D. Anderson Cancer Center report in the July 9 edition of Cancer Cell.
› Verified 6 days ago
Dr. Daniel S Romm, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, (117), Biloxi, MS 39531 Phone: 228-523-4557 Fax: 228-523-4517 |